Idorsia Ltd (IDIA.SW)
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
6.34+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+81.7%
The outlook
Idorsia Ltd currently reads as leaning bullish based on above its 50- & 200-day averages, 76% of the way from its 52-week low to high, avg target -26% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range76% of the way from its 52-week low to high
Price targetAvg target -26% vs current price
Analyst price target
~12-month · 3 analysts4.67average target-26.4% vs now
Now 6.34
Low 4.50High 5.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.62B
52-wk high
7.56
52-wk low
2.42
50-day avg
5.55
200-day avg
4.15
Trailing P/E
—